To clarify the treatment of certain DNA Specimen Provenance Assay tests as reasonable and necessary for the diagnosis or treatment of illness for coverage under the Medicare program.
The bill’s titles are written by its sponsor.
Sponsor and status
Sponsor. Representative for Indiana's 8th congressional district. Republican.
Last Updated: Jul 13, 2016
Length: 3 pages
Jul 13, 2016
114th Congress, 2015–2017
Died in a previous Congress
This bill was introduced on July 13, 2016, in a previous session of Congress, but was not enacted.
Jul 13, 2016
Oct 4, 2017
Reintroduced Bill — Ordered Reported
This activity took place on a related bill, H.R. 2557.
H.R. 5763 (114th) was a bill in the United States Congress.
How to cite this information.
Civic Impulse. (2018). H.R. 5763 — 114th Congress: Prostate Cancer Misdiagnosis Elimination Act of 2016. Retrieved from https://www.govtrack.us/congress/bills/114/hr5763
“H.R. 5763 — 114th Congress: Prostate Cancer Misdiagnosis Elimination Act of 2016.” www.GovTrack.us. 2016. February 19, 2018 <https://www.govtrack.us/congress/bills/114/hr5763>
|title=H.R. 5763 (114th)
|accessdate=February 19, 2018
|author=114th Congress (2016)
|date=July 13, 2016
|quote=Prostate Cancer Misdiagnosis Elimination Act of 2016